# Southwest Hospital, China: Phase 4 study completed, 806 enrolled (Acute Ischemic Stroke Patients)

**Score:** 65/100

| Field | Value |
|---|---|
| Sponsor | Southwest Hospital, China |
| Sponsor type | Academic and hospital |
| Study | Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients |
| NCT ID | NCT07294209 |
| Phase | Phase 4 |
| Status | completed |
| Conditions | Acute Ischemic Stroke Patients |
| Intervention types | drug |
| Target enrollment | 806 |
| Site countries | China |
| Posted | 2025-12-19 |
| Planned start | 2025-12-19 |
| Event | Completed |
| Event date | 2026-11-01 |
| Last update posted | 2026-11-03 |

## Why this score
- Posted in the last two weeks.
- Completed: closeout, analysis and the next study ahead.
- 806 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07294209). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.